20160502 CCMG-CCGM - Trainee Poster Presentations - Session 2

TMG-204 Characterization of VHL promoter variants in patients suspected of Von Hippel Lindau
Dr. Saleh Albanyan

TMG-206 Increased nuchal translucency and Noonan syndrome spectrum – A Mount Sinai hospital experience
Dr. Pierre Sinajon

TMG-208 Second family with Mabry Syndrome caused by PIGL mutation
Dr. Ruqaiah Altassan

TMG-214 Discrepant Sanger and NGS sequencing results for an Ehlers-Danlos syndrome (EDS) III pathogenic variant in the high homology gene TNXB
Dr. Michelle Axford

TMG-218 Specific Antibody Deficiency In A Patient With Ring Chromosome 18
Dr. Mehdi Yeganeh

TMG-220 Understanding the Molecular Mechanisms in Pyruvate Dehydrogenase Deficiency Outcomes and Treatment
Dr. James O'Byrne

	Did Not Attend	Poor	Fair	Good	Very Good	Excellent
TMG-204 Characterization of VHL promoter variants in patients suspected of Von Hippel Lindau	TMG-204 Characterization of VHL promoter variants in patients suspected of Von Hippel Lindau Did Not Attend	TMG-204 Characterization of VHL promoter variants in patients suspected of Von Hippel Lindau Poor	TMG-204 Characterization of VHL promoter variants in patients suspected of Von Hippel Lindau Fair	TMG-204 Characterization of VHL promoter variants in patients suspected of Von Hippel Lindau Good	TMG-204 Characterization of VHL promoter variants in patients suspected of Von Hippel Lindau Very Good	TMG-204 Characterization of VHL promoter variants in patients suspected of Von Hippel Lindau Excellent
TMG-206 Increased nuchal translucency and Noonan syndrome spectrum – A Mount Sinai hospital experience	TMG-206 Increased nuchal translucency and Noonan syndrome spectrum – A Mount Sinai hospital experience Did Not Attend	TMG-206 Increased nuchal translucency and Noonan syndrome spectrum – A Mount Sinai hospital experience Poor	TMG-206 Increased nuchal translucency and Noonan syndrome spectrum – A Mount Sinai hospital experience Fair	TMG-206 Increased nuchal translucency and Noonan syndrome spectrum – A Mount Sinai hospital experience Good	TMG-206 Increased nuchal translucency and Noonan syndrome spectrum – A Mount Sinai hospital experience Very Good	TMG-206 Increased nuchal translucency and Noonan syndrome spectrum – A Mount Sinai hospital experience Excellent
TMG-208 Second family with Mabry Syndrome caused by PIGL mutation	TMG-208 Second family with Mabry Syndrome caused by PIGL mutation Did Not Attend	TMG-208 Second family with Mabry Syndrome caused by PIGL mutation Poor	TMG-208 Second family with Mabry Syndrome caused by PIGL mutation Fair	TMG-208 Second family with Mabry Syndrome caused by PIGL mutation Good	TMG-208 Second family with Mabry Syndrome caused by PIGL mutation Very Good	TMG-208 Second family with Mabry Syndrome caused by PIGL mutation Excellent
TMG-214 Discrepant Sanger and NGS sequencing results for an Ehlers-Danlos syndrome (EDS) III pathogenic variant in the high homology gene TNXB	TMG-214 Discrepant Sanger and NGS sequencing results for an Ehlers-Danlos syndrome (EDS) III pathogenic variant in the high homology gene TNXB Did Not Attend	TMG-214 Discrepant Sanger and NGS sequencing results for an Ehlers-Danlos syndrome (EDS) III pathogenic variant in the high homology gene TNXB Poor	TMG-214 Discrepant Sanger and NGS sequencing results for an Ehlers-Danlos syndrome (EDS) III pathogenic variant in the high homology gene TNXB Fair	TMG-214 Discrepant Sanger and NGS sequencing results for an Ehlers-Danlos syndrome (EDS) III pathogenic variant in the high homology gene TNXB Good	TMG-214 Discrepant Sanger and NGS sequencing results for an Ehlers-Danlos syndrome (EDS) III pathogenic variant in the high homology gene TNXB Very Good	TMG-214 Discrepant Sanger and NGS sequencing results for an Ehlers-Danlos syndrome (EDS) III pathogenic variant in the high homology gene TNXB Excellent
TMG-218 Specific Antibody Deficiency In A Patient With Ring Chromosome 18	TMG-218 Specific Antibody Deficiency In A Patient With Ring Chromosome 18 Did Not Attend	TMG-218 Specific Antibody Deficiency In A Patient With Ring Chromosome 18 Poor	TMG-218 Specific Antibody Deficiency In A Patient With Ring Chromosome 18 Fair	TMG-218 Specific Antibody Deficiency In A Patient With Ring Chromosome 18 Good	TMG-218 Specific Antibody Deficiency In A Patient With Ring Chromosome 18 Very Good	TMG-218 Specific Antibody Deficiency In A Patient With Ring Chromosome 18 Excellent
TMG-220 Understanding the Molecular Mechanisms in Pyruvate Dehydrogenase Deficiency Outcomes and Treatment	TMG-220 Understanding the Molecular Mechanisms in Pyruvate Dehydrogenase Deficiency Outcomes and Treatment Did Not Attend	TMG-220 Understanding the Molecular Mechanisms in Pyruvate Dehydrogenase Deficiency Outcomes and Treatment Poor	TMG-220 Understanding the Molecular Mechanisms in Pyruvate Dehydrogenase Deficiency Outcomes and Treatment Fair	TMG-220 Understanding the Molecular Mechanisms in Pyruvate Dehydrogenase Deficiency Outcomes and Treatment Good	TMG-220 Understanding the Molecular Mechanisms in Pyruvate Dehydrogenase Deficiency Outcomes and Treatment Very Good	TMG-220 Understanding the Molecular Mechanisms in Pyruvate Dehydrogenase Deficiency Outcomes and Treatment Excellent

Did Not Attend

Poor

Fair

Good

Very Good

Excellent

TMG-204 Characterization of VHL promoter variants in patients suspected of Von Hippel Lindau

TMG-204 Characterization of VHL promoter variants in patients suspected of Von Hippel Lindau Did Not Attend

TMG-204 Characterization of VHL promoter variants in patients suspected of Von Hippel Lindau Poor

TMG-204 Characterization of VHL promoter variants in patients suspected of Von Hippel Lindau Fair

TMG-204 Characterization of VHL promoter variants in patients suspected of Von Hippel Lindau Good

TMG-204 Characterization of VHL promoter variants in patients suspected of Von Hippel Lindau Very Good

TMG-204 Characterization of VHL promoter variants in patients suspected of Von Hippel Lindau Excellent

TMG-206 Increased nuchal translucency and Noonan syndrome spectrum – A Mount Sinai hospital experience

TMG-206 Increased nuchal translucency and Noonan syndrome spectrum – A Mount Sinai hospital experience Did Not Attend

TMG-206 Increased nuchal translucency and Noonan syndrome spectrum – A Mount Sinai hospital experience Poor

TMG-206 Increased nuchal translucency and Noonan syndrome spectrum – A Mount Sinai hospital experience Fair

TMG-206 Increased nuchal translucency and Noonan syndrome spectrum – A Mount Sinai hospital experience Good

TMG-206 Increased nuchal translucency and Noonan syndrome spectrum – A Mount Sinai hospital experience Very Good

TMG-206 Increased nuchal translucency and Noonan syndrome spectrum – A Mount Sinai hospital experience Excellent

TMG-208 Second family with Mabry Syndrome caused by PIGL mutation

TMG-208 Second family with Mabry Syndrome caused by PIGL mutation Did Not Attend

TMG-208 Second family with Mabry Syndrome caused by PIGL mutation Poor

TMG-208 Second family with Mabry Syndrome caused by PIGL mutation Fair

TMG-208 Second family with Mabry Syndrome caused by PIGL mutation Good

TMG-208 Second family with Mabry Syndrome caused by PIGL mutation Very Good

TMG-208 Second family with Mabry Syndrome caused by PIGL mutation Excellent

TMG-214 Discrepant Sanger and NGS sequencing results for an Ehlers-Danlos syndrome (EDS) III pathogenic variant in the high homology gene TNXB

TMG-214 Discrepant Sanger and NGS sequencing results for an Ehlers-Danlos syndrome (EDS) III pathogenic variant in the high homology gene TNXB Did Not Attend

TMG-214 Discrepant Sanger and NGS sequencing results for an Ehlers-Danlos syndrome (EDS) III pathogenic variant in the high homology gene TNXB Poor

TMG-214 Discrepant Sanger and NGS sequencing results for an Ehlers-Danlos syndrome (EDS) III pathogenic variant in the high homology gene TNXB Fair

TMG-214 Discrepant Sanger and NGS sequencing results for an Ehlers-Danlos syndrome (EDS) III pathogenic variant in the high homology gene TNXB Good

TMG-214 Discrepant Sanger and NGS sequencing results for an Ehlers-Danlos syndrome (EDS) III pathogenic variant in the high homology gene TNXB Very Good

TMG-214 Discrepant Sanger and NGS sequencing results for an Ehlers-Danlos syndrome (EDS) III pathogenic variant in the high homology gene TNXB Excellent

TMG-218 Specific Antibody Deficiency In A Patient With Ring Chromosome 18

TMG-218 Specific Antibody Deficiency In A Patient With Ring Chromosome 18 Did Not Attend

TMG-218 Specific Antibody Deficiency In A Patient With Ring Chromosome 18 Poor

TMG-218 Specific Antibody Deficiency In A Patient With Ring Chromosome 18 Fair

TMG-218 Specific Antibody Deficiency In A Patient With Ring Chromosome 18 Good

TMG-218 Specific Antibody Deficiency In A Patient With Ring Chromosome 18 Very Good

TMG-218 Specific Antibody Deficiency In A Patient With Ring Chromosome 18 Excellent

TMG-220 Understanding the Molecular Mechanisms in Pyruvate Dehydrogenase Deficiency Outcomes and Treatment

TMG-220 Understanding the Molecular Mechanisms in Pyruvate Dehydrogenase Deficiency Outcomes and Treatment Did Not Attend

TMG-220 Understanding the Molecular Mechanisms in Pyruvate Dehydrogenase Deficiency Outcomes and Treatment Poor

TMG-220 Understanding the Molecular Mechanisms in Pyruvate Dehydrogenase Deficiency Outcomes and Treatment Fair

TMG-220 Understanding the Molecular Mechanisms in Pyruvate Dehydrogenase Deficiency Outcomes and Treatment Good

TMG-220 Understanding the Molecular Mechanisms in Pyruvate Dehydrogenase Deficiency Outcomes and Treatment Very Good

TMG-220 Understanding the Molecular Mechanisms in Pyruvate Dehydrogenase Deficiency Outcomes and Treatment Excellent

	Strongly Disagree	Disagree	Neutral	Agree	Strongly Agree
Sufficient time was allowed for audience participation/active learning	Sufficient time was allowed for audience participation/active learning Strongly Disagree	Sufficient time was allowed for audience participation/active learning Disagree	Sufficient time was allowed for audience participation/active learning Neutral	Sufficient time was allowed for audience participation/active learning Agree	Sufficient time was allowed for audience participation/active learning Strongly Agree
The facilities were satisfactory	The facilities were satisfactory Strongly Disagree	The facilities were satisfactory Disagree	The facilities were satisfactory Neutral	The facilities were satisfactory Agree	The facilities were satisfactory Strongly Agree
The session was free from commercial bias	The session was free from commercial bias Strongly Disagree	The session was free from commercial bias Disagree	The session was free from commercial bias Neutral	The session was free from commercial bias Agree	The session was free from commercial bias Strongly Agree
Overall, I would rate this Symposium as excellent	Overall, I would rate this Symposium as excellent Strongly Disagree	Overall, I would rate this Symposium as excellent Disagree	Overall, I would rate this Symposium as excellent Neutral	Overall, I would rate this Symposium as excellent Agree	Overall, I would rate this Symposium as excellent Strongly Agree

Strongly Disagree

Disagree

Neutral

Agree

Strongly Agree

Sufficient time was allowed for audience participation/active learning

Sufficient time was allowed for audience participation/active learning Strongly Disagree

Sufficient time was allowed for audience participation/active learning Disagree

Sufficient time was allowed for audience participation/active learning Neutral

Sufficient time was allowed for audience participation/active learning Agree

Sufficient time was allowed for audience participation/active learning Strongly Agree

The facilities were satisfactory

The facilities were satisfactory Strongly Disagree

The facilities were satisfactory Disagree

The facilities were satisfactory Neutral

The facilities were satisfactory Agree

The facilities were satisfactory Strongly Agree

The session was free from commercial bias

The session was free from commercial bias Strongly Disagree

The session was free from commercial bias Disagree

The session was free from commercial bias Neutral

The session was free from commercial bias Agree

The session was free from commercial bias Strongly Agree

Overall, I would rate this Symposium as excellent

Overall, I would rate this Symposium as excellent Strongly Disagree

Overall, I would rate this Symposium as excellent Disagree

Overall, I would rate this Symposium as excellent Neutral

Overall, I would rate this Symposium as excellent Agree

Overall, I would rate this Symposium as excellent Strongly Agree

20160502 CCMG-CCGM - Trainee Poster Presentations - Session 2 - Even Numbers

Interactive session with the authors of poster presentations.

Question Title

* 1. Please Rate Each Session:

Question Title

* 2. Please assess the Sessions as a whole

Question Title

* 3. As a result of attending these sessions, I am planning to:

Question Title

* 4. Please explain any changes you plan to make or personal learning projects you will pursue as a result of this session:

Question Title

* 5. Please indicate which CanMEDS roles you felt were addressed during this educational activity. (Select all that apply)

Question Title

* 6. General comments about individual speakers:

Question Title

* 7. What topics would you like to be addressed at future conferences to keep you up to date in your profession?